Novel Regulators of Glucose Homeostasis in Aging
衰老过程中血糖稳态的新型调节剂
基本信息
- 批准号:8459465
- 负责人:
- 金额:$ 30.72万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-05-01 至 2013-12-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAffectAgeAged, 80 and overAgingAlzheimer&aposs DiseaseApoptosisApoptoticAttenuatedBiologicalBiological FactorsBlood GlucoseBody CompositionBody fatBrainCardiovascular DiseasesCellsChronicClinicalComplexCytokine ReceptorsDataDependovirusDiabetes MellitusDiseaseDoseEnergy MetabolismEtiologyEuglycemic ClampingFatty acid glycerol estersFunctional disorderGlucose ClampGoalsHepaticHomeostasisHomologous GeneHumanHypothalamic structureIncidenceInfusion proceduresInsulinInsulin ResistanceInsulin-Like Growth Factor ILeadLinkLiverMammalsMediatingMediator of activation proteinMemory LossMetabolicMitochondriaModelingMolecularMusMuscleMyocardial IschemiaNeuraxisNeuronsNon-Insulin-Dependent Diabetes MellitusPathogenesisPathologyPatientsPeptidesPeripheralPhysiologicalPlasmaPlayPrevalencePreventionRattusResearchRiskRodentRodent ModelRoleScopolamineSerumSignal PathwaySkeletal MuscleStrokeSystemTechniquesTechnologyTestingTherapeuticTissuesVascular Smooth MuscleVisceralage relatedanalogbaseblood glucose regulationcarbohydrate metabolismdiabetes riskdiabeticglucose disposalglucose metabolismglucose productionhumaninimprovedinsulin sensitivityinsulin sensitizing drugsneuron lossneurotoxicitynoveloverexpressionpublic health relevancereceptorresponse
项目摘要
DESCRIPTION (provided by applicant): Biological changes associated with aging are a major risk for increased incidence of many age-related diseases including insulin resistance/type 2 diabetes mellitus, Alzheimer's disease (AD), stroke and ischemic heart disease. The focus of our research has been to identify biological factors that change with age and may be involved in the etiology or pathogenesis of age-related diseases. A novel mitochondrial peptide, Humanin (HN), has been recognized for its cyto-protective role due to its anti-apoptotic function in many tissues, especially AD related insults. In addition, HN is closely linked to the IGF system, which is recognized for its role in aging. In our preliminary data we show that that HN levels in tissues and secretions decrease with age. We also show that HN significantly improves overall insulin sensitivity both at the liver and skeletal muscle in young rats. Furthermore, molecular manipulations of HN create potent humanin analogs (that interact with IGF-1 system) that can reproduce the effects of native endogenous HN. Based on our preliminary data, we hypothesize that the decrease in HN levels increase risk of insulin resistance and diabetes in aging rodents, and this effect is mediated through the hypothalamus. Furthermore, we hypothesize that administration of HN to aging rodents will substantially alter the risk of diabetes. Using state of the art technology, we propose to evaluate the role of HN in the integral features that leads to the impaired glucose metabolism in aging: a) diminished ability of insulin to restrain the production of glucose from the liver (or hepatic glucose production) and/or to promote the disposal of glucose in peripheral tissues, in part by a central mechanism, and b) increase in fat especially visceral fat. HN represents a novel molecular link between impaired carbohydrate metabolism, diabetes and neuro-degeneration, and may provide not only mechanistic explanations but also potential therapeutic options in this common clinical constellation affecting millions of people.
描述(申请人提供):与衰老相关的生物变化是许多与年龄相关的疾病发病率增加的主要风险,包括胰岛素抵抗/2型糖尿病、阿尔茨海默病(AD)、中风和缺血性心脏病。我们研究的重点一直是确定随年龄变化的生物学因素,这些因素可能与年龄相关疾病的病因或发病机制有关。人蛋白(HN)是一种新型的线粒体多肽,在许多组织,特别是AD相关损伤中具有抗细胞凋亡的功能,因此被认为具有细胞保护作用。此外,HN与IGF系统密切相关,IGF系统因其在衰老中的作用而被公认。在我们的初步数据中,我们显示组织和分泌物中的HN水平随着年龄的增长而下降。我们还表明,HN显著改善了年轻大鼠肝脏和骨骼肌的整体胰岛素敏感性。此外,HN的分子操作产生了强大的人蛋白类似物(与IGF-1系统相互作用),可以复制天然内源性HN的效果。根据我们的初步数据,我们假设HN水平的降低会增加老年啮齿动物患胰岛素抵抗和糖尿病的风险,这种影响是通过下丘脑介导的。此外,我们假设,给老年啮齿动物服用HN将显著改变糖尿病的风险。利用最先进的技术,我们建议评估HN在导致衰老过程中糖代谢受损的整体特征中的作用:a)胰岛素抑制肝脏产生葡萄糖的能力减弱(或肝脏葡萄糖产生)和/或部分通过中枢机制促进外周组织中葡萄糖的处置,以及b)脂肪增加,特别是内脏脂肪增加。HN代表了碳水化合物代谢受损、糖尿病和神经退行性变之间的一种新的分子联系,并可能不仅提供机制上的解释,而且可能在这个影响数百万人的常见临床星座上提供潜在的治疗选择。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Radhika Hiren Muzumdar其他文献
Radhika Hiren Muzumdar的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Radhika Hiren Muzumdar', 18)}}的其他基金
Novel Regulators of Glucose Homeostasis in Aging
衰老过程中血糖稳态的新型调节剂
- 批准号:
8068345 - 财政年份:2010
- 资助金额:
$ 30.72万 - 项目类别:
Novel Regulators of Glucose Homeostasis in Aging
衰老过程中血糖稳态的新型调节剂
- 批准号:
8114665 - 财政年份:2010
- 资助金额:
$ 30.72万 - 项目类别:
Novel Regulators of Glucose Homeostasis in Aging
衰老过程中血糖稳态的新型调节剂
- 批准号:
8817892 - 财政年份:2010
- 资助金额:
$ 30.72万 - 项目类别:
Novel Regulators of Glucose Homeostasis in Aging
衰老过程中血糖稳态的新型调节剂
- 批准号:
8277249 - 财政年份:2010
- 资助金额:
$ 30.72万 - 项目类别:
CNS/IGF-axis in modulation of body composition in aging
CNS/IGF 轴在衰老过程中调节身体成分
- 批准号:
7913491 - 财政年份:2009
- 资助金额:
$ 30.72万 - 项目类别:
CNS/IGF-axis in modulation of body composition in aging
CNS/IGF 轴在衰老过程中调节身体成分
- 批准号:
7896468 - 财政年份:2007
- 资助金额:
$ 30.72万 - 项目类别:
CNS/IGF-axis in modulation of body composition in aging
CNS/IGF 轴在衰老过程中调节身体成分
- 批准号:
8111754 - 财政年份:2007
- 资助金额:
$ 30.72万 - 项目类别:
CNS/IGF-axis in modulation of body composition in aging
CNS/IGF 轴在衰老过程中调节身体成分
- 批准号:
7467975 - 财政年份:2007
- 资助金额:
$ 30.72万 - 项目类别:
CNS/IGF-axis in modulation of body composition in aging
CNS/IGF 轴在衰老过程中调节身体成分
- 批准号:
7260075 - 财政年份:2007
- 资助金额:
$ 30.72万 - 项目类别:
CNS/IGF-axis in modulation of body composition in aging
CNS/IGF 轴在衰老过程中调节身体成分
- 批准号:
7671336 - 财政年份:2007
- 资助金额:
$ 30.72万 - 项目类别:
相似海外基金
Hormone therapy, age of menopause, previous parity, and APOE genotype affect cognition in aging humans.
激素治疗、绝经年龄、既往产次和 APOE 基因型会影响老年人的认知。
- 批准号:
495182 - 财政年份:2023
- 资助金额:
$ 30.72万 - 项目类别:
Investigating how alternative splicing processes affect cartilage biology from development to old age
研究选择性剪接过程如何影响从发育到老年的软骨生物学
- 批准号:
2601817 - 财政年份:2021
- 资助金额:
$ 30.72万 - 项目类别:
Studentship
RAPID: Coronavirus Risk Communication: How Age and Communication Format Affect Risk Perception and Behaviors
RAPID:冠状病毒风险沟通:年龄和沟通方式如何影响风险认知和行为
- 批准号:
2029039 - 财政年份:2020
- 资助金额:
$ 30.72万 - 项目类别:
Standard Grant
Neighborhood and Parent Variables Affect Low-Income Preschool Age Child Physical Activity
社区和家长变量影响低收入学龄前儿童的身体活动
- 批准号:
9888417 - 财政年份:2019
- 资助金额:
$ 30.72万 - 项目类别:
The affect of Age related hearing loss for cognitive function
年龄相关性听力损失对认知功能的影响
- 批准号:
17K11318 - 财政年份:2017
- 资助金额:
$ 30.72万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
10166936 - 财政年份:2017
- 资助金额:
$ 30.72万 - 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
9320090 - 财政年份:2017
- 资助金额:
$ 30.72万 - 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
9761593 - 财政年份:2017
- 资助金额:
$ 30.72万 - 项目类别:
How age dependent molecular changes in T follicular helper cells affect their function
滤泡辅助 T 细胞的年龄依赖性分子变化如何影响其功能
- 批准号:
BB/M50306X/1 - 财政年份:2014
- 资助金额:
$ 30.72万 - 项目类别:
Training Grant
Inflamm-aging: What do we know about the effect of inflammation on HIV treatment and disease as we age, and how does this affect our search for a Cure?
炎症衰老:随着年龄的增长,我们对炎症对艾滋病毒治疗和疾病的影响了解多少?这对我们寻找治愈方法有何影响?
- 批准号:
288272 - 财政年份:2013
- 资助金额:
$ 30.72万 - 项目类别:
Miscellaneous Programs